MedTrace Logo

PeRioperative Omega Three and the Effect on ImmuNity

NCT03598413 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 40

Last updated 2022-09-28

No results posted yet for this study

Summary

Bowel cancer is the second most common cause of cancer-related death in the UK, with 50,000 new cases and over 15,000 deaths annually. Surgery is the mainstay of treatment and the most common complications are an infection of the wound or lungs. These can lengthen hospital stay, reduce the quality of life, and even increase the risk of death. Bowel cancer patients are often malnourished. Optimising nutrition with supplements such as fish-oils can improve the immune response of patients, helping prevent such complications, shorten hospital stay, improve quality of life and overall survival.

Conditions

  • Colorectal Cancer
  • Nutritional Deficiency
  • Infected Wound
  • Surgical Site Infection
  • Complication, Postoperative
  • Surgery
  • Surgery--Complications
  • Sarcopenia
  • Phagocytic Dysfunction

Interventions

DIETARY_SUPPLEMENT

Omega-3

200ml, pre-mixed oral nutritional supplement supplying 1.42g per bottle of EPA and DHA.

Sponsors & Collaborators

  • Royal Surrey County Hospital NHS Foundation Trust

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
SINGLE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-07-16
Primary Completion
2019-09-19
Completion
2019-09-19

Countries

  • United Kingdom

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03598413 on ClinicalTrials.gov